ZA852042B - Crystalline ceftazidime salts - Google Patents

Crystalline ceftazidime salts

Info

Publication number
ZA852042B
ZA852042B ZA852042A ZA852042A ZA852042B ZA 852042 B ZA852042 B ZA 852042B ZA 852042 A ZA852042 A ZA 852042A ZA 852042 A ZA852042 A ZA 852042A ZA 852042 B ZA852042 B ZA 852042B
Authority
ZA
South Africa
Prior art keywords
salts
crystalline ceftazidime
ceftazidime
crystalline
ceftazidime salts
Prior art date
Application number
ZA852042A
Other languages
English (en)
Inventor
Ta-Sen Chou
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA852042B publication Critical patent/ZA852042B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA852042A 1984-03-26 1985-03-19 Crystalline ceftazidime salts ZA852042B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/593,441 US4537959A (en) 1984-03-26 1984-03-26 Crystalline cephalosporin antibiotic salt

Publications (1)

Publication Number Publication Date
ZA852042B true ZA852042B (en) 1986-10-29

Family

ID=24374724

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA852042A ZA852042B (en) 1984-03-26 1985-03-19 Crystalline ceftazidime salts

Country Status (16)

Country Link
US (1) US4537959A (pt)
EP (1) EP0157538A3 (pt)
JP (1) JPS60215689A (pt)
KR (1) KR870000829B1 (pt)
AU (1) AU575137B2 (pt)
CA (1) CA1228851A (pt)
DK (1) DK131785A (pt)
ES (1) ES8606358A1 (pt)
GR (1) GR850708B (pt)
HU (1) HU194253B (pt)
IL (1) IL74671A0 (pt)
NZ (1) NZ211509A (pt)
PH (1) PH21943A (pt)
PT (1) PT80133B (pt)
SU (1) SU1356963A3 (pt)
ZA (1) ZA852042B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
AT387390B (de) * 1986-10-07 1989-01-10 Biochemie Gmbh Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3788279T2 (de) * 1987-06-25 1994-06-16 Banyu Pharma Co Ltd Kristalline cephalosporinzusammensetzungen, verfahren und zwischenprodukte für ihre herstellung.
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
DE10158488A1 (de) † 2001-11-28 2003-06-12 Wolff Cellulosics Gmbh & Co Kg Lösungsverzögerte Celluloseether und ein Verfahren zu ihrer Herstellung
CN102924483B (zh) * 2012-10-31 2015-06-17 海南合瑞制药股份有限公司 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
SE449996B (sv) * 1979-10-02 1987-06-01 Glaxo Group Ltd (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)acetamidol/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat i form av en kristallin bishydroklorid farmaceutisk komposition derav samt anvendning som mellanpr
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim

Also Published As

Publication number Publication date
DK131785D0 (da) 1985-03-22
HU194253B (en) 1988-01-28
ES541505A0 (es) 1986-04-16
KR870000829B1 (ko) 1987-04-23
EP0157538A3 (en) 1986-10-08
GR850708B (pt) 1985-07-19
AU575137B2 (en) 1988-07-21
AU4025085A (en) 1985-10-03
PH21943A (en) 1988-04-15
EP0157538A2 (en) 1985-10-09
PT80133B (en) 1987-03-23
US4537959A (en) 1985-08-27
JPS60215689A (ja) 1985-10-29
NZ211509A (en) 1987-11-27
PT80133A (en) 1985-04-01
ES8606358A1 (es) 1986-04-16
KR850006425A (ko) 1985-10-05
DK131785A (da) 1985-09-27
IL74671A0 (en) 1985-06-30
SU1356963A3 (ru) 1987-11-30
HUT36798A (en) 1985-10-28
CA1228851A (en) 1987-11-03

Similar Documents

Publication Publication Date Title
GB8401005D0 (en) Formate salts
MY8700126A (en) Crystalline venzothiazine dioxide salts
DE3569533D1 (en) Phosphonic-acid salts
ZA852042B (en) Crystalline ceftazidime salts
EP0146389A3 (en) Crystalline silicophosphoaluminate
ZA857613B (en) Crystalline cephalosporin hydrohalide salts
GB8309584D0 (en) Crystalline zincosilicate
SG64491G (en) Disperant salts
GB8503799D0 (en) Oxydicarboxylic acid salts
ZA823764B (en) Crystalline benzothiazine dioxide salts
ZA859129B (en) Crystalline galloborosilicates
EP0146390A3 (en) Crystalline silicophosphoaluminate
EP0146388A3 (en) Crystalline silicophosphoaluminate
GB8709632D0 (en) Crystalline compounds
GB2157284B (en) 6-b-halopenicillanic acid salts
ZA849726B (en) Crystalline silicophosphoaluminate
GB8414046D0 (en) Crystalline salts
IE842313L (en) Crystalline benzothiazine salts
GB8709633D0 (en) Crystalline compounds
IE841527L (en) Cephalosporin salts
IE850743L (en) Ceftazidime salts
IE841576L (en) Methyllevallorphanium salts
GB8507473D0 (en) Phenoxypropanolamine salts
ZA856444B (en) Cyclimmonium salts
GB2167750B (en) Isothiuronium salts